About
Conditionally-active Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalSan Diego & Southern California
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
1,052
By Phase
PHASE1: 1PHASE2: 3PHASE1/PHASE2: 3
By Status
COMPLETED: 4RECRUITING: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05808634Lead Sponsor
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
PHASE1Recruiting
168 participants
Started: Jul 14, 2023 · Completed: Sep 15, 2028
NCT05271604Lead Sponsor
A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
PHASE2Completed
42 participants
Started: Dec 13, 2022 · Completed: Sep 22, 2025
NCT05180799Lead Sponsor
A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
PHASE1/PHASE2Active, not recruiting
320 participants
Started: Aug 3, 2022 · Completed: Jun 30, 2026
NCT04918186Collaborator
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
PHASE2Recruiting
60 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
NCT04681131Lead Sponsor
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC
PHASE2Completed
85 participants
Started: Mar 17, 2021 · Completed: Jul 9, 2025
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...